These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 20460162)

  • 1. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
    Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail.
    Berger B; Donzelli M; Maseneni S; Boess F; Roth A; Krähenbühl S; Haschke M
    Front Pharmacol; 2016; 7():443. PubMed ID: 27917125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells.
    Klein M; Thomas M; Hofmann U; Seehofer D; Damm G; Zanger UM
    Drug Metab Dispos; 2015 Feb; 43(2):273-83. PubMed ID: 25480923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes.
    Rubin K; Janefeldt A; Andersson L; Berke Z; Grime K; Andersson TB
    Drug Metab Dispos; 2015 Jan; 43(1):119-25. PubMed ID: 25371393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
    Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
    Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
    Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
    Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
    Andersson TB; Kanebratt KP; Kenna JG
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures.
    Jackson JP; Li L; Chamberlain ED; Wang H; Ferguson SS
    Drug Metab Dispos; 2016 Sep; 44(9):1463-79. PubMed ID: 27338863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
    Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
    Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug metabolism testing using blood-monocyte derivatives.
    Gómez-Icazbalceta G; González-Sánchez I; Moreno J; Cerbón MA; Cervantes A
    Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1571-80. PubMed ID: 23984653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.